TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Team Select Home Care says its CareSight AI platform now covers 100% of its patient census through respiratory, cardiac and infection models. Company data shared with Home Health Care News show a 14.9% year-over-year decline in hospitalizations from April through August 2026; the figures have not been independently verified in the supplied report.
Team Select Home Care says its predictive AI platform, CareSight AI, now covers all of its patients and that hospitalization rates fell 14.9% year over year between April and August 2026. The Phoenix-based provider shared the company’s outcome data with Home Health Care News; the figures are company-reported and the source does not describe an independent evaluation.
CareSight uses more than a decade of Team Select patient data and monitors up to eight vital signs alongside nurses’ notes and reported changes in condition. The system is designed to identify potential clinical decline so care teams can respond before a patient needs hospital care. The company says its three current models address respiratory conditions, cardiac conditions and infections, with each patient covered by at least one model.
The reported decline compares hospitalization rates from April through August 2026 with the same five months in 2025. Team Select President and CEO Fred Johnson told the publication that the company had already recorded relatively low hospitalization rates before CareSight. He cited a seven-state Medicaid claims study commissioned by Team Select, which found monthly 30-day hospitalization rates of 3% to 8% for the company, compared with an industry range of 10% to 20% per month. The report does not provide the underlying claims data or details on the study’s methods.
CareSight’s development proceeded in stages. Team Select first built a respiratory model, then a cardiac model, followed by an infection model. Johnson said the respiratory model took three years to develop, the cardiac model six months and the infection model 90 days. The company says the later models benefited from data preparation and lessons learned during earlier development.
Hospital Data Could Shape Payer Deals
The results could affect how Team Select negotiates reimbursement as it seeks more value-based contracts. In those arrangements, payment can be tied to outcomes or total care costs, rather than relying only on traditional fee-for-service rates. Johnson said the company plans to use hospitalization and cost data to make its case to payers, especially when rate increases are difficult to secure.
For patients with complex needs, avoiding an unnecessary hospital stay may mean care can continue at home. For the provider, the potential business value depends on whether the reported reductions hold up across a wider period and whether payers accept the evidence when setting contract terms. The published figures describe an association during the period after the models were deployed; they do not establish that the AI alone caused the decline.
Team Select is also redeveloping payer scorecards to show measures such as patient satisfaction, hospitalization rates and emergency department visits for each payer’s patients, with comparisons to industry averages. Those tools could give payers more detail for evaluating performance, but the report does not say when the scorecards will be available or what contract changes have already resulted.
Popular right now
Dyson V8 Cyclone Cordless Vacuum
Bose QuietComfort Ultra Wireless Noise-Cancelling Headphones with Spatial Audio, Black
TCL QM64L 85-Inch QD-Mini LED 4K Smart Fire TV
As an affiliate, we earn on qualifying purchases.
Three Models Built in Stages
Team Select serves medically complex children and seniors in the home and operates in 16 states. The company launched CareSight in 2025 after investing $6 million in the effort, according to Home Health Care News. Private equity firm Court Square Capital Partners invested in Team Select in 2023.
The first CareSight model focused on respiratory patients because the company identified respiratory care as a starting point among conditions linked to hospitalizations. Johnson said the initial system generated too many alerts, including alerts for vital-sign readings outside general parameters that were normal for a particular patient. Team Select added patient-specific comparisons using each person’s historical baseline, which Johnson said helped reduce false positives. The company later added cardiac and infection models to extend coverage across its census.
The expansion reflects a broader operational bet: Team Select says a long history of integrated patient data gives it an advantage in developing predictive tools. Johnson has described the technology as a competitive differentiator, but the report does not compare CareSight’s performance with other providers’ systems.
“I knew that if we could do this, not only would it be a long-lasting competitive advantage … [it] would significantly decrease those hospitalizations even further.”
— Fred Johnson, Team Select Home Care president and CEO
How Much Did AI Drive the Decline?
The 14.9% decline comes from company data shared with Home Health Care News. The source does not provide patient counts, hospitalization totals, statistical analysis, a control group or an independent audit. It is not clear how the company calculated the rate, whether patient mix or other care changes affected the comparison, or whether the reduction continued after August 2026.
The earlier 3% to 8% monthly rate and 10% to 20% industry range are figures Johnson attributed to a study commissioned by Team Select. The report does not include the study itself, its methodology or enough detail to determine how directly its comparison applies to the newer five-month results. The company’s reported outcome should not be read as proof that CareSight caused the change or that the same result will occur at other providers.
Diabetes Model Is in Development
Team Select is developing a fourth CareSight model focused on diabetes, according to the report. The company has not provided a launch date or explained how the new model will be evaluated. It also plans to continue pursuing value-based payer agreements and is redeveloping payer scorecards, though no specific contract awards or rollout schedule were reported.
The next points to watch are whether Team Select publishes longer-term results, provides fuller information about its measures and methods, and reports whether payers use the data to change contracts. Until further evidence is available, the 2026 reduction remains a company-reported result from a five-month year-over-year comparison.
Key Questions
What did Team Select announce?
Team Select says CareSight AI now covers 100% of its patient census through respiratory, cardiac and infection models. It also reported a 14.9% year-over-year decline in hospitalization rates for April-August 2026.
Is the 14.9% decline independently verified?
The source article says the data came from Team Select. It does not describe an independent audit or provide a separate verification of the reported decline.
What does CareSight monitor?
The platform monitors up to eight vital signs, along with nurses’ notes and changes in a patient’s condition, according to Team Select. Its models are designed to flag potential decline related to respiratory, cardiac or infection risks.
What is Team Select developing next?
The company is building a fourth model focused on diabetes. The report does not give an expected release date.
Source: rss
